Related Experiment Video
Updated: Aug 7, 2026

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
Primary pulmonary arterial hypertension presenting as diffuse micronodules on CT
1Johns Hopkins University School of Medicine, Division of Pulmonary and Critical Care Medicine, Department of Pathology, Baltimore, Maryland 21205, USA. mhorton2@jhmi.edu
This study details a rare case of pulmonary arterial hypertension linked to anorexigen use, presenting unusually with diffuse lung micronodules on CT scans. Biopsy confirmed these were plexogenic arterial lesions, highlighting an atypical radiographic presentation for this condition.
Area of Science:
- Cardiology
- Radiology
- Pulmonology
Background:
- Primary pulmonary arterial hypertension (PAH) is a rare, lethal condition.
- PAH is characterized by enlarged pulmonary arteries, vascular pruning, and cardiomegaly, typically with clear lung fields.
- Anorexigen use is an associated, though not fully understood, cause of PAH.
Observation:
- A patient with a history of fenfluramine and phentermine use presented with diffuse micronodules on computed tomography (CT).
- This radiographic presentation is unusual for primary pulmonary arterial hypertension.
- Lung biopsy was performed to investigate the cause of the micronodules.
Findings:
- Lung biopsy confirmed the diffuse micronodules were radiographic manifestations of extensive, diffuse plexogenic arterial lesions.
- Plexogenic arteriopathy is a known, albeit rare, complication associated with anorexigen use.
- This case demonstrates an atypical CT finding in anorexigen-related PAH.
Implications:
- This case highlights the importance of considering anorexigen exposure in patients with unexplained PAH.
- The findings suggest that diffuse micronodules on high-resolution CT scans can be a radiographic manifestation of anorexigen-related pulmonary arterial hypertension.
- Further research may be warranted to understand the spectrum of radiographic presentations in drug-induced PAH.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

